Article · Journal · 2025

Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy

Mohamed S. Nafie, Mavis Ali, Moayad Abdullah Alwehaibi, Abdulmajeed Abdullah Alayyaf, Muhanna K. Al-Muhanna, Naif Almuqati and 5 more

RSC Advances

• Open access · Gold
• World top 10%
• International · 5 countries

Read it10.1039/d4ra05966b